Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries

J. Samol; I. Demedts; M. Erman; V. Kozlov; J. N. Minatta; F. V. Moiseenko; M. S. Paats; S. J. Rajappa; T. Bailey; H. Wallis; M. Madondo; D. Kahangire; M. Zukin

Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries

J. Samol
, I. Demedts
, M. Erman
, V. Kozlov
, J. N. Minatta
, F. V. Moiseenko
, M. S. Paats
, S. J. Rajappa
, T. Bailey
, H. Wallis
, M. Madondo
, D. Kahangire
, M. Zukin

Tan Tock Seng Hospital
Pulm Dis
Dept Prevent Oncol
University of Buenos Aires
Chemotherapy Dept
Erasmus University Rotterdam
Adelphi Group Ltd
AstraZeneca
Dept Med Oncol

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S55-S56
Number of pages	2
Journal	Journal of Thoracic Oncology
Volume	18
Issue number	4
Publication status	Published - Apr 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Samol, J., Demedts, I., Erman, M., Kozlov, V., Minatta, J. N., Moiseenko, F. V., Paats, M. S., Rajappa, S. J., Bailey, T., Wallis, H., Madondo, M., Kahangire, D., & Zukin, M. (2023). Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries. Journal of Thoracic Oncology, 18(4), S55-S56.

@article{d075668b7e7c4316a287e19ccaa57788,

title = "Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries",

author = "J. Samol and I. Demedts and M. Erman and V. Kozlov and Minatta, \{J. N.\} and Moiseenko, \{F. V.\} and Paats, \{M. S.\} and Rajappa, \{S. J.\} and T. Bailey and H. Wallis and M. Madondo and D. Kahangire and M. Zukin",

year = "2023",

month = apr,

language = "English",

volume = "18",

pages = "S55--S56",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "4",

}

Samol, J, Demedts, I, Erman, M, Kozlov, V, Minatta, JN, Moiseenko, FV, Paats, MS, Rajappa, SJ, Bailey, T, Wallis, H, Madondo, M, Kahangire, D & Zukin, M 2023, 'Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries', Journal of Thoracic Oncology, vol. 18, no. 4, pp. S55-S56.

TY - JOUR

T1 - Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries

AU - Samol, J.

AU - Demedts, I.

AU - Erman, M.

AU - Kozlov, V.

AU - Minatta, J. N.

AU - Moiseenko, F. V.

AU - Paats, M. S.

AU - Rajappa, S. J.

AU - Bailey, T.

AU - Wallis, H.

AU - Madondo, M.

AU - Kahangire, D.

AU - Zukin, M.

PY - 2023/4

Y1 - 2023/4

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000995007600027&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 1556-0864

VL - 18

SP - S55-S56

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4

ER -

Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries

UN SDGs

Other files and links

Cite this